These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19662512)

  • 1. High resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibe.
    Dietrich T; Hucko T; Bourayou R; Jahnke C; Paetsch I; Atrott K; Stawowy P; Gräfe M; Klein C; Schnackenburg B; Fleck E; Graf K
    Int J Cardiovasc Imaging; 2009 Dec; 25(8):827-36. PubMed ID: 19662512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis.
    Graf K; Dietrich T; Tachezy M; Scholle FD; Licha K; Stawowy P; Grafe M; Hauff P; Fleck E
    Mol Imaging; 2008; 7(2):68-76. PubMed ID: 18706289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice.
    Davis HR; Compton DS; Hoos L; Tetzloff G
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2032-8. PubMed ID: 11742881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.
    Braun A; Yesilaltay A; Acton S; Broschat KO; Krul ES; Napawan N; Stagliano N; Krieger M
    Atherosclerosis; 2008 May; 198(1):77-84. PubMed ID: 18054357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ezetimibe on atherosclerosis in preclinical models.
    Davis HR; Lowe RS; Neff DR
    Atherosclerosis; 2011 Apr; 215(2):266-78. PubMed ID: 21397230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice.
    Kuhlencordt PJ; Padmapriya P; Rützel S; Schödel J; Hu K; Schäfer A; Huang PL; Ertl G; Bauersachs J
    Atherosclerosis; 2009 Jan; 202(1):48-57. PubMed ID: 18479686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
    Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
    Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice.
    Liu J; Lu H; Howatt DA; Balakrishnan A; Moorleghen JJ; Sorci-Thomas M; Cassis LA; Daugherty A
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1826-34. PubMed ID: 26044581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice.
    Zhang X; Xiao S; Li Q
    J Int Med Res; 2018 Aug; 46(8):3365-3373. PubMed ID: 30058421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia.
    Trogan E; Fayad ZA; Itskovich VV; Aguinaldo JG; Mani V; Fallon JT; Chereshnev I; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1714-9. PubMed ID: 15256400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular protective effects of ezetimibe in ApoE-deficient mice.
    Nakagami H; Osako MK; Takami Y; Hanayama R; Koriyama H; Mori M; Hayashi H; Shimizu H; Morishita R
    Atherosclerosis; 2009 Mar; 203(1):51-8. PubMed ID: 18603252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between hemodynamics and atherosclerosis in aortic arches of apolipoprotein E-null mice on 129S6/SvEvTac and C57BL/6J genetic backgrounds.
    Tomita H; Hagaman J; Friedman MH; Maeda N
    Atherosclerosis; 2012 Jan; 220(1):78-85. PubMed ID: 22078246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid quantification of aortic lesions in apoE(-/-) mice.
    Beattie JH; Duthie SJ; Kwun IS; Ha TY; Gordon MJ
    J Vasc Res; 2009; 46(4):347-52. PubMed ID: 19142014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo.
    Heim C; Gebhardt J; Ramsperger-Gleixner M; Jacobi J; Weyand M; Ensminger SM
    Heart Vessels; 2016 May; 31(5):783-94. PubMed ID: 26062773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI follow-up of TNF-dependent differential progression of atherosclerotic wall-thickening in mouse aortic arch from early to advanced stages.
    Kober F; Canault M; Peiretti F; Mueller C; Kopp F; Alessi MC; Cozzone PJ; Nalbone G; Bernard M
    Atherosclerosis; 2007 Dec; 195(2):e93-9. PubMed ID: 17662986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of in vivo monitoring of abdominal aortic atherosclerosis by high field magnetic resonance imaging in apoE-/- mice fed a high fat diet or infused with angiotensin II].
    ZHAO R; YAO YY; DENG G; JU SH; WANG ZJ; WEN S; CHEN J; JIN H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):823-8. PubMed ID: 21092653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Antiatherogenic Properties of Ezetimibe Using
    Dumas LS; Briand F; Clerc R; Brousseau E; Montemagno C; Ahmadi M; Bacot S; Soubies A; Perret P; Riou LM; Devoogdt N; Lahoutte T; Barone-Rochette G; Fagret D; Ghezzi C; Sulpice T; Broisat A
    J Nucl Med; 2017 Jul; 58(7):1088-1093. PubMed ID: 28280218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.